In this study, we explored the impact of a new cell culture device on rapidly expanding melanoma TIL, demonstrated its ability to rescue poor growth and proposed a rationale behind the preferable expansion of a subset of CD8+ T cells that has been shown to correlate with clinical response to TIL ACT.3,7. This evidence concerns the gene CD8A and melanoma.